Semaglutide use was associated with a lower risk for opioid overdose than other antidiabetic medications in comorbid type 2 diabetes and OUD.

Primary hyperparathyroidism glands were distinguishable on the basis of disease and number of glands with near-infrared autofluorescence imaging.

HealthDay News — A pair of American scientists have won the 2024 Nobel Prize in medicine for their discovery of microRNA, tiny genetic molecules that play a crucial role in how genes shape the body.

Hurricane Helene knocked out a North Carolina production plant for a major supplier of IV fluids for U.S. hospitals.

A survey has found that, in cardiology, burnout is common among health care workers, with nurses reporting the highest rates of burnout.

A missed or delayed diagnosis of chronic liver disease is associated with cirrhosis or hepatocellular carcinoma.

A diabetes management program was associated with improved glycemic control among youth with type 1 diabetes transitioning into adult care.

Perinatal HIV was associated with whole body and lumbar spine bone mineral density deficits and slower bone area accrual among children.

Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

A 1-dose human papillomavirus (HPV) vaccination program is projected to prevent a similar number of cervical cancers as a 2-dose program.

Electronic health record (EHR) documentation seen in primary care does not accurately reflect menopause symptom burden.

The FDA has accepted the NDA for elinzanetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.